Cargando…

Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study

Background: The complex isolation and purification process of hepatocytes for transplantation is labor intensive and with great contamination risk. Here, as a pilot and feasibility study, we examined in vitro and in vivo hepatocyte isolation feasibility and cell function of Cell Saver(®) Elite(®), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ya-Hui, Chen, Hui-Ling, Ho, Cheng-Maw, Chen, Hung-Yen, Ho, Shu-Li, Hu, Rey-Heng, Lee, Po-Huang, Chang, Mei-Hwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143084/
https://www.ncbi.nlm.nih.gov/pubmed/33919203
http://dx.doi.org/10.3390/jpm11050326
_version_ 1783696683093196800
author Chen, Ya-Hui
Chen, Hui-Ling
Ho, Cheng-Maw
Chen, Hung-Yen
Ho, Shu-Li
Hu, Rey-Heng
Lee, Po-Huang
Chang, Mei-Hwei
author_facet Chen, Ya-Hui
Chen, Hui-Ling
Ho, Cheng-Maw
Chen, Hung-Yen
Ho, Shu-Li
Hu, Rey-Heng
Lee, Po-Huang
Chang, Mei-Hwei
author_sort Chen, Ya-Hui
collection PubMed
description Background: The complex isolation and purification process of hepatocytes for transplantation is labor intensive and with great contamination risk. Here, as a pilot and feasibility study, we examined in vitro and in vivo hepatocyte isolation feasibility and cell function of Cell Saver(®) Elite(®), an intraoperative blood-cell-recovery system. Methods: Rat and pig liver cells were collected using this system and then cultured in vitro, and their hepatocyte-specific enzymes were characterized. We then transplanted the hepatocytes in an established acute liver–injured (retrorsine+D-galactosamine-treated) rat model for engraftment. Recipient rats were sacrificed 1, 2, and 4 weeks after transplantation, followed by donor-cell identification and histological, serologic, and immunohistopathological examination. To demonstrate this Cell Saver(®) strategy is workable in the first place, traditional (classical) strategy, in our study, behaved as certainty during the cell manufacturing process for monitoring quality assurance throughout the course, from the start of cell isolation to post-transplantation. Results: We noted that in situ collagenase perfusion was followed by filtration, centrifugation, and collection in the Cell Saver(®) until the process ended. Most (>85%) isolated cells were hepatocytes (>80% viability) freshly demonstrating hepatocyte nuclear factor 4α and carbamoyl-phosphate synthase 1 (a key enzyme in the urea cycle), and proliferating through intercellular contact in culture, with expression of albumin and CYP3A4. After hepatocyte transplantation in dipeptidyl peptidase IV (−/−) rat liver, wild-type donor hepatocytes engrafted and repopulated progressively in 4 weeks with liver functional improvement. Proliferating donor hepatocyte–native biliary ductular cell interaction was identified. Post-transplantation global liver functional recovery after Cell Saver and traditional methods was comparable. Conclusions: Cell Saver(®) requires reduced manual manipulation for isolating transplantable hepatocytes.
format Online
Article
Text
id pubmed-8143084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81430842021-05-25 Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study Chen, Ya-Hui Chen, Hui-Ling Ho, Cheng-Maw Chen, Hung-Yen Ho, Shu-Li Hu, Rey-Heng Lee, Po-Huang Chang, Mei-Hwei J Pers Med Article Background: The complex isolation and purification process of hepatocytes for transplantation is labor intensive and with great contamination risk. Here, as a pilot and feasibility study, we examined in vitro and in vivo hepatocyte isolation feasibility and cell function of Cell Saver(®) Elite(®), an intraoperative blood-cell-recovery system. Methods: Rat and pig liver cells were collected using this system and then cultured in vitro, and their hepatocyte-specific enzymes were characterized. We then transplanted the hepatocytes in an established acute liver–injured (retrorsine+D-galactosamine-treated) rat model for engraftment. Recipient rats were sacrificed 1, 2, and 4 weeks after transplantation, followed by donor-cell identification and histological, serologic, and immunohistopathological examination. To demonstrate this Cell Saver(®) strategy is workable in the first place, traditional (classical) strategy, in our study, behaved as certainty during the cell manufacturing process for monitoring quality assurance throughout the course, from the start of cell isolation to post-transplantation. Results: We noted that in situ collagenase perfusion was followed by filtration, centrifugation, and collection in the Cell Saver(®) until the process ended. Most (>85%) isolated cells were hepatocytes (>80% viability) freshly demonstrating hepatocyte nuclear factor 4α and carbamoyl-phosphate synthase 1 (a key enzyme in the urea cycle), and proliferating through intercellular contact in culture, with expression of albumin and CYP3A4. After hepatocyte transplantation in dipeptidyl peptidase IV (−/−) rat liver, wild-type donor hepatocytes engrafted and repopulated progressively in 4 weeks with liver functional improvement. Proliferating donor hepatocyte–native biliary ductular cell interaction was identified. Post-transplantation global liver functional recovery after Cell Saver and traditional methods was comparable. Conclusions: Cell Saver(®) requires reduced manual manipulation for isolating transplantable hepatocytes. MDPI 2021-04-21 /pmc/articles/PMC8143084/ /pubmed/33919203 http://dx.doi.org/10.3390/jpm11050326 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Ya-Hui
Chen, Hui-Ling
Ho, Cheng-Maw
Chen, Hung-Yen
Ho, Shu-Li
Hu, Rey-Heng
Lee, Po-Huang
Chang, Mei-Hwei
Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title_full Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title_fullStr Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title_full_unstemmed Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title_short Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
title_sort preclinical application of reduced manipulated processing strategy to collect transplantable hepatocytes: a pilot and feasibility study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143084/
https://www.ncbi.nlm.nih.gov/pubmed/33919203
http://dx.doi.org/10.3390/jpm11050326
work_keys_str_mv AT chenyahui preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT chenhuiling preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT hochengmaw preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT chenhungyen preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT hoshuli preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT hureyheng preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT leepohuang preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy
AT changmeihwei preclinicalapplicationofreducedmanipulatedprocessingstrategytocollecttransplantablehepatocytesapilotandfeasibilitystudy